Long Term Prophylactic Therapy of Congenital Long QT Syndrome Type III (LQT3) With Ranolazine

Condition:   Long QT Syndrome Type 3Intervention:   Drug: RanolazineSponsor:   Tel-Aviv Sourasky Medical CenterRecruiting - verified March 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials